Results 31 to 40 of about 6,520,232 (298)

Supplementary Data from Cell–Cell Interactions Drive Metastasis of Circulating Tumor Microemboli

, 2022
Supplementary Data from Cell–Cell Interactions Drive Metastasis of Circulating Tumor ...
Sebastian Schölch (14958867), Lei Zhu (14958861), Christoph Reißfelder (14958864), Jianxin Tao (14958858), Mina Yakoub (11601259), Sonja Loges (181586)   +5 more
core   +1 more source

Plasma next generation sequencing and droplet digital PCR‐based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent‐line osimertinib

Thoracic Cancer, 2019
Background Gene mutation analysis from plasma circulating tumor DNA (ctDNA) can provide timely information regarding the mechanism of resistance that could translate to personalised treatment.
Pei N. Ding, Therese Becker, Victoria Bray, Wei Chua, Yafeng Ma, Bo Xu, David Lynch, Paul de Souza, Tara Roberts   +8 more
doaj   +1 more source

Circulating Tumor Cell Composition in Renal Cell Carcinoma. [PDF]

PLoS ONE, 2016
PURPOSE:Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a "liquid biopsy" in solid tumors. However, successful application in metastatic renal cell carcinoma (mRCC) has been very limited so
Ivonne Nel, Thomas C Gauler, Kira Bublitz, Lazaros Lazaridis, André Goergens, Bernd Giebel, Martin Schuler, Andreas-Claudius Hoffmann   +7 more
doaj   +1 more source

Spearman correlation for CCT2 tumor stain score, circulating tumor cell (CTC) count, and time gap.

, 2022
Spearman correlation for CCT2 tumor stain score, circulating tumor cell (CTC) count, and time gap.
Carlos Alemany (12937026), Elizabeth Griffith (1323738), Louis Barr (12937023), Annette R. Khaled (181666), Heba Ghozlan (10169090), Eunkyung Lee (1862767), Na’im Fanaian (8987786), S. A. Litherland (12937032), Amr S. Khaled (8987783), Xiang Zhu (135451), Amanda Cox (5073860), Rebecca Moroose (12937020), Ryan Sause (12937029), Ana Martini (12937017)   +13 more
core   +1 more source

Algorithm to identify circulating tumor cell clusters using in vivo flow cytometer [PDF]

Journal of Innovative Optical Health Sciences, 2018
Recent studies in oncology have addressed the importance of detecting circulating tumor cell clusters because circulating tumor cell clusters might survive and metastasize more easily than single circulating tumor cells.
Kai Pang, Dan Wei, Pengfei Hai, Zhangru Yang, Xiaofu Weng, Xunbin Wei   +5 more
doaj   +1 more source

Detection of Circulating Tumor Cells [PDF]

Scientifica, 2014
The increasing number of treatment options for patients with metastatic carcinomas has created an accompanying need for methods to determine if the tumor will be responsive to the intended therapy and to monitor its effectiveness. Ideally, these methods would be noninvasive and provide quantitative real-time analysis of tumor activity in a variety of ...
Sanne de Wit, Guus van Dalum, Leon W. M. M. Terstappen   +2 more
openaire   +3 more sources

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma

Biosensors, 2022
While patients with resectable pancreatic ductal adenocarcinoma (PDAC) show improved survival compared to their non-resectable counterparts, survival remains low owing to occult metastatic disease and treatment resistance.
Pablo J. Dopico, Minh-Chau N. Le, Benjamin Burgess, Zhijie Yang, Yu Zhao, Youxiang Wang, Thomas J. George, Z. Hugh Fan   +7 more
doaj   +1 more source

The biology of circulating tumor cells [PDF]

Oncogene, 2015
Metastasis is a biologically complex process consisting of numerous stochastic events which may tremendously differ across various cancer types. Circulating tumor cells (CTCs) are cells that are shed from primary tumors and metastatic deposits into the blood stream.
K Pantel, M R Speicher
openaire   +2 more sources

Liquid Biopsy: Detection of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma

, 2020
Circulating tumor cells (CTC) harvested in the blood of patients with esophageal squamous cell carcinoma (ESCC) are associated with certain clinical pathological parameters as well as patients’ prognosis and response to chemoradiation.
Lam, AK, Hamid, FB, Faysal Bin Hamid, Vinod Gopalan, Gopalan, V, Alfred K. Lam   +5 more
core   +1 more source

Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth [PDF]

, 2009
Background: Anti-cancer chemotherapy can be simultaneously lymphodepleting and immunostimulatory. Pre-clinical models clearly demonstrate that chemotherapy can synergize with immunotherapy, raising the question how the immune system can be mobilized to ...
Amy Prosser, Robinson, B.W.S., Currie, A.J., Scalzo, A.A., Joanne Salmons, Robbert G van der Most, Mark J Smyth, Bruce W S Robinson, Salmons, J., Lake, R.A., Smyth Mark J., Andrew J Currie, Amanda L Cleaver, Prosser, Amy, van der Most, R.G., Degli-Esposti, M.A., Salmons, Joanne, Lake, Richard A., Prosser, A., Prosser Amy, Nowak, A.K., Currie, Andrew J., van der Most Robbert G., Smyth, M.J., Robinson Bruce W. S., Lake Richard A., Degli-Esposti, Mariapia A., Scalzo Anthony A., Currie Andrew J., Nowak, Anna K., Sathish Mahendran, Cleaver, Amanda L., Richard A Lake, Nowak Anna K., van der Most, Robbert G., Larma, I., Mahendran, S., Anna K Nowak, Degli-Esposti Mariapia A., Anthony A Scalzo, Cleaver, A.L., Robinson, Bruce W.S., Larma, Irma, Irma Larma, Cleaver Amanda L., Smyth, Mark J., Larma Irma, Mehendran, Sathish, Scalzo, Anthony A., Salmons Joanne, Mahendran Sathish, Mariapia A Degli-Esposti   +51 more
core   +2 more sources